NCT06762808 2025-08-15
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
M.D. Anderson Cancer Center
Phase 2 Withdrawn
M.D. Anderson Cancer Center
ProgenaBiome
Massachusetts General Hospital
Massachusetts General Hospital
University of Alabama at Birmingham
Case Comprehensive Cancer Center